{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:57:47Z","timestamp":1761512267902},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1038\/sj.bmt.1705411","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T22:41:16Z","timestamp":1152225676000},"page":"157-167","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation"],"prefix":"10.1038","volume":"38","author":[{"given":"A","family":"Pachnio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Humpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schwake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gramatzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,5]]},"reference":[{"key":"BF1705411_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bmt.1703535","volume":"29","author":"A Urbano-Ispizua","year":"2002","unstructured":"Urbano-Ispizua A, Schmitz N, de Witte T, Frassoni F, Rosti G, Schrezenmeier H et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639\u2013646.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705411_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/stem.140473","volume":"14","author":"JL Ferrara","year":"1996","unstructured":"Ferrara JL, Cooke KR, Pan L, Krenger W . The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996; 14: 473\u2013489.","journal-title":"Stem Cells"},{"key":"BF1705411_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1705411_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/bmj.2.4993.626","volume":"32","author":"DW Barnes","year":"1956","unstructured":"Barnes DW, Corp MJ, Loutit JF, Neal FE . Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication. BMJ 1956; 32: 626\u2013627.","journal-title":"BMJ"},{"key":"BF1705411_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.178.2.703","volume":"178","author":"PJ Martin","year":"1993","unstructured":"Martin PJ . Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 1993; 178: 703\u2013712.","journal-title":"J Exp Med"},{"key":"BF1705411_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood.V97.2.383","volume":"97","author":"A Urbano-Ispizua","year":"2001","unstructured":"Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S et al. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood 2001; 97: 383\u2013387.","journal-title":"Blood"},{"key":"BF1705411_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/15258160050079425","volume":"9","author":"D Simpson","year":"2000","unstructured":"Simpson D . Drug therapy for acute graft-versus-host disease prophylaxis. J Hematother Stem Cell Res 2000; 9: 317\u2013325.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1705411_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00277-004-0890-7","volume":"83","author":"R Zeiser","year":"2004","unstructured":"Zeiser R, Marks R, Bertz H, Finke J . Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Ann Hematol 2004; 83: 551\u2013565.","journal-title":"Ann Hematol"},{"key":"BF1705411_CR9","first-page":"437","volume":"3","author":"PJ Martin","year":"1988","unstructured":"Martin PJ, Hansen JA, Torok-Storb B, Moretti L, Press O, Storb R et al. Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease. Bone Marrow Transplant 1988; 3: 437\u2013444.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705411_CR10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","volume":"83","author":"CR Li","year":"1994","unstructured":"Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR . Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971\u20131979.","journal-title":"Blood"},{"key":"BF1705411_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/shem.2002.29251","volume":"39","author":"M Cavazzana-Calvo","year":"2002","unstructured":"Cavazzana-Calvo M, Andre-Schmutz I, Hacein-Bey-Abina S, Bensoussan D, Le Deist F, Fischer A . Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation. Semin Hematol 2002; 39: 32\u201340.","journal-title":"Semin Hematol"},{"key":"BF1705411_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007890-199007000-00001","volume":"50","author":"M Cavazzana-Calvo","year":"1990","unstructured":"Cavazzana-Calvo M, Fromont M, Le Deist F, Lusardi M, Coulombel L, Derocq JM et al. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin. Transplantation 1990; 50: 1\u20137.","journal-title":"Transplantation"},{"key":"BF1705411_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1046\/j.1365-2141.2000.02074.x","volume":"109","author":"B Fehse","year":"2000","unstructured":"Fehse B, Frerk O, Goldman M, Bulduk M, Zander AR . Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69). Br J Haematol 2000; 109: 644\u2013651.","journal-title":"Br J Haematol"},{"key":"BF1705411_CR14","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1182\/blood.V99.8.3041","volume":"99","author":"UF Hartwig","year":"2002","unstructured":"Hartwig UF, Robbers M, Wickenhauser C, Huber C . Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death. Blood 2002; 99: 3041\u20133049.","journal-title":"Blood"},{"key":"BF1705411_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1182\/blood.V99.9.3083","volume":"99","author":"BJ Chen","year":"2002","unstructured":"Chen BJ, Cui X, Liu C, Chao NJ . Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002; 99: 3083\u20133088.","journal-title":"Blood"},{"key":"BF1705411_CR16","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1182\/blood.V89.12.4636","volume":"89","author":"JL Cohen","year":"1997","unstructured":"Cohen JL, Boyer O, Salomon B, Onclercq R, Charlotte F, Bruel S et al. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 1997; 89: 4636\u20134645.","journal-title":"Blood"},{"key":"BF1705411_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nm915","volume":"9","author":"M Edinger","year":"2003","unstructured":"Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9: 1144\u20131150.","journal-title":"Nat Med"},{"key":"BF1705411_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.20020399","volume":"196","author":"P Hoffmann","year":"2002","unstructured":"Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389\u2013399.","journal-title":"J Exp Med"},{"key":"BF1705411_CR19","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","volume":"95","author":"L Gao","year":"2000","unstructured":"Gao L, Bellantuono I, Elsasser A, Marley SB, Gordon MY, Goldman JM et al. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 2000; 95: 2198\u20132203.","journal-title":"Blood"},{"key":"BF1705411_CR20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.V83.4.1060.1060","volume":"83","author":"D van der Harst","year":"1994","unstructured":"van der Harst D, Goulmy E, Falkenburg JH, Kooij-Winkelaar YM, van Luxemburg-Heijs SA, Goselink HM et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994; 83: 1060\u20131066.","journal-title":"Blood"},{"key":"BF1705411_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0022-1759(00)00231-3","volume":"243","author":"AB Lyons","year":"2000","unstructured":"Lyons AB . Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243: 147\u2013154.","journal-title":"J Immunol Methods"},{"key":"BF1705411_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","volume":"166","author":"EJ Suchin","year":"2001","unstructured":"Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA . Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 2001; 166: 973\u2013981.","journal-title":"J Immunol"},{"key":"BF1705411_CR23","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1182\/blood.V98.10.3156","volume":"98","author":"S Maury","year":"2001","unstructured":"Maury S, Salomon B, Klatzmann D, Cohen JL . Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice. Blood 2001; 98: 3156\u20133158.","journal-title":"Blood"},{"key":"BF1705411_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1182\/blood-2003-04-1098","volume":"103","author":"WR Godfrey","year":"2004","unstructured":"Godfrey WR, Krampf MR, Taylor PA, Blazar BR . Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 2004; 103: 1158\u20131165.","journal-title":"Blood"},{"key":"BF1705411_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/bjc.1972.24","volume":"26","author":"L Parr","year":"1972","unstructured":"Parr L . Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer 1972; 26: 174\u2013177.","journal-title":"Br J Cancer"},{"key":"BF1705411_CR26","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.4049\/jimmunol.161.10.5268","volume":"161","author":"PE Fields","year":"1998","unstructured":"Fields PE, Finch RJ, Gray GS, Zollner R, Thomas JL, Sturmhoefel K et al. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells. J Immunol 1998; 161: 5268\u20135275.","journal-title":"J Immunol"},{"key":"BF1705411_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/immu.200390003","volume":"33","author":"C Beck","year":"2003","unstructured":"Beck C, Schreiber K, Schreiber H, Rowley DA . C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum. Eur J Immunol 2003; 33: 19\u201328.","journal-title":"Eur J Immunol"},{"key":"BF1705411_CR28","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1073\/pnas.92.14.6254","volume":"92","author":"LP Seung","year":"1995","unstructured":"Seung LP, Rowley DA, Dubey P, Schreiber H . Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci USA 1995; 92: 6254\u20136258.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1705411_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.147.1.22","volume":"147","author":"K Hestdal","year":"1991","unstructured":"Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991; 147: 22\u201328.","journal-title":"J Immunol"},{"key":"BF1705411_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/146532402320776026","volume":"4","author":"J Storek","year":"2002","unstructured":"Storek J . B-cell immunity after allogeneic hematopoietic cell transplantation. Cytotherapy 2002; 4: 423\u2013424.","journal-title":"Cytotherapy"},{"key":"BF1705411_CR31","first-page":"387","volume":"12","author":"J Storek","year":"1993","unstructured":"Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A . B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387\u2013398.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705411_CR32","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood.V90.4.1694","volume":"90","author":"B Glass","year":"1997","unstructured":"Glass B, Uharek L, Zeis M, Dreger P, Loffler H, Steinmann J et al. Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect. Blood 1997; 90: 1694\u20131700.","journal-title":"Blood"},{"key":"BF1705411_CR33","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1182\/blood-2002-02-0419","volume":"100","author":"AD Billiau","year":"2002","unstructured":"Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M . Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Blood 2002; 100: 1894\u20131902.","journal-title":"Blood"},{"key":"BF1705411_CR34","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","volume":"68","author":"P Mombaerts","year":"1992","unstructured":"Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE . RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869\u2013877.","journal-title":"Cell"},{"key":"BF1705411_CR35","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1182\/blood.V100.12.3877","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877\u20133886.","journal-title":"Blood"},{"key":"BF1705411_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","volume":"103","author":"HJ Kolb","year":"2004","unstructured":"Kolb HJ, Schmid C, Barrett AJ, Schendel DJ . Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004; 103: 767\u2013776.","journal-title":"Blood"},{"key":"BF1705411_CR37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.03135.x","volume":"115","author":"S Maury","year":"2001","unstructured":"Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001; 115: 630\u2013641.","journal-title":"Br J Haematol"},{"key":"BF1705411_CR38","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood.V96.9.3290","volume":"96","author":"J Storek","year":"2000","unstructured":"Storek J, Espino G, Dawson MA, Storer B, Flowers ME, Maloney DG . Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 2000; 96: 3290\u20133293.","journal-title":"Blood"},{"key":"BF1705411_CR39","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V83.11.3390.3390","volume":"83","author":"KR Oettel","year":"1994","unstructured":"Oettel KR, Wesly OH, Albertini MR, Hank JA, Iliopolis O, Sosman JA et al. Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph1+) human leukemia lines can also recognize Ph1\u2212 cells from the same patient. Blood 1994; 83: 3390\u20133402.","journal-title":"Blood"},{"key":"BF1705411_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.175.1.139","volume":"175","author":"S Singh","year":"1992","unstructured":"Singh S, Ross SR, Acena M, Rowley DA, Schreiber H . Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med 1992; 175: 139\u2013146.","journal-title":"J Exp Med"},{"key":"BF1705411_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1074-7613(02)00480-6","volume":"17","author":"MT Spiotto","year":"2002","unstructured":"Spiotto MT, Yu P, Rowley DA, Nishimura MI, Meredith SC, Gajewski TF et al. Increasing tumor antigen expression overcomes \u2018ignorance\u2019 to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002; 17: 737\u2013747.","journal-title":"Immunity"},{"key":"BF1705411_CR42","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.4049\/jimmunol.165.9.4901","volume":"165","author":"BR Blazar","year":"2000","unstructured":"Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W et al. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J Immunol 2000; 165: 4901\u20134909.","journal-title":"J Immunol"},{"key":"BF1705411_CR43","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.V94.4.1201","volume":"94","author":"JH Falkenburg","year":"1999","unstructured":"Falkenburg JH, Wafelman AR, Joosten P, Smit WM, van Bergen CA, Bongaerts R et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999; 94: 1201\u20131208.","journal-title":"Blood"},{"key":"BF1705411_CR44","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.0530192100","volume":"100","author":"WA Marijt","year":"2003","unstructured":"Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742\u20132747.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705411","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T23:55:52Z","timestamp":1683503752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["BF1705411"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705411","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,1]]},"assertion":[{"value":"27 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}